LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million ...
AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...
Irish Independent on MSN2d
Flu is leading to school absences but uptake of vaccine low – survey revealsMore than one in two Irish parents say their child missed schools days in the past year due to flu or flu-like symptoms with ...
No evidence of human transmission, but virus found in increasing number of animals World Health Organization says H5N1's risk ...
The Irish Patients Association is calling on parents and guardians of children to join together with them in ‘Flunion’ in the ...
AstraZeneca’s new U.S. spending also leaves in doubt the pharmaceutical company’s plans to invest in a vaccine site in ...
The company said it aims to expand its U.S. presence by the end of 2026. The new spending will be for a research-and-development center in Cambridge, Mass.; manufacturing plants in Maryland and Texas, ...
On the heels of releasing its latest financial statement, Vancouver-based biotechnology company Absci announced it has met its first milestone in its collaboration with pharmaceutical giant AstraZenec ...
Glamour on MSN1d
The RSV Vaccine for Infants: Everything Parents Need to KnowThe other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...
Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...
The holidays are fast approaching along with cooler weather and various respiratory illnesses. Here's when to get your ...
The Food and Drug Administration has cleared Novavax to move forward with testing of a combination vaccine for COVID-19 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback